Skip to main content
Premium Trial:

Request an Annual Quote

Will We Never Get Cheery News from the IP Team?

In a perspectives essay posted on Venture Beat, Sergio Garcia and Michael Davis-Wilson from law firm Fenwick & West discuss the current patent landscape in light of the Supreme Court's ruling this year in MedImmune v. Genentech, which they say "effectively paved the way for more frequent patent challenges that could disadvantage smaller companies and organizations." That's especially relevant for this field. "The post-MedImmune environment presents an acute challenge for small biotech companies and universities," the authors write. "These organizations generally have limited funds to fight patent lawsuits and might therefore face stepped-up legal attacks on their patents."

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.